Geode Capital Management LLC Boosts Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Geode Capital Management LLC grew its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,348,745 shares of the company's stock after purchasing an additional 21,951 shares during the quarter. Geode Capital Management LLC owned approximately 2.73% of Prestige Consumer Healthcare worth $105,342,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its holdings in Prestige Consumer Healthcare by 3.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company's stock worth $19,630,000 after acquiring an additional 8,533 shares during the last quarter. Avior Wealth Management LLC grew its stake in shares of Prestige Consumer Healthcare by 1,570.7% in the fourth quarter. Avior Wealth Management LLC now owns 8,554 shares of the company's stock worth $668,000 after purchasing an additional 8,042 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Prestige Consumer Healthcare by 5.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock valued at $49,667,000 after purchasing an additional 33,844 shares during the period. Norges Bank bought a new position in Prestige Consumer Healthcare during the 4th quarter valued at approximately $40,009,000. Finally, Barclays PLC lifted its holdings in Prestige Consumer Healthcare by 346.3% in the 3rd quarter. Barclays PLC now owns 92,444 shares of the company's stock worth $6,665,000 after buying an additional 71,730 shares during the period. Institutional investors own 99.95% of the company's stock.

Remove Ads

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of recent analyst reports. Royal Bank of Canada upped their target price on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a report on Friday, March 21st. Raymond James upgraded shares of Prestige Consumer Healthcare to a "moderate buy" rating in a report on Thursday, December 19th. StockNews.com lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th. Canaccord Genuity Group increased their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Finally, DA Davidson lifted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $93.33.

Prestige Consumer Healthcare Stock Down 0.2 %

Shares of PBH stock traded down $0.15 during trading hours on Tuesday, hitting $81.97. 24,895 shares of the company's stock traded hands, compared to its average volume of 283,593. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The stock has a market cap of $4.06 billion, a price-to-earnings ratio of 19.20, a PEG ratio of 2.69 and a beta of 0.47. The stock's fifty day simple moving average is $84.69 and its two-hundred day simple moving average is $79.97. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.